Researchmoz added Most up-to-date research on "Global Schizophrenia
Therapeutics Market 2017-2021" to its huge collection of research
reports.
About Schizophrenia Therapeutics
Schizophrenia is a chronic mental disorder that alters the perception, thinking, and social behavior of an individual. Individuals suffering from this disease face difficulty in distinguishing between imaginary things and reality. Although schizophrenia is not as prevalent as other mental disorders, it affects 7 or 8 individuals out of 1,000 people. Globally, the disease affects 1% of the total population. Schizophrenic patients are usually diagnosed with low levels of dopamine and serotonin. These are major neurotransmitters in the brain and are responsible for transmitting nerve signals from one neuron to another neuron. Deficiency of these neurons in the brain leads to impairment of thinking, perception, and the activity of an individual. At present, the treatment regimen for this disease focuses on relieving symptoms. Thus, antipsychotic drugs are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.
Technavios analysts forecast the global schizophrenia therapeutics market to grow at a CAGR of 1.84% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global schizophrenia therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1267319
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Schizophrenia Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Other prominent vendors
Alkermes
Bristol-Myers Squibb
Market driver
Increasing expenditure on prescription drugs
For a full, detailed list, view our report
Market challenge
Technological advances in non-invasive neuromodulation devices
For a full, detailed list, view our report
Market trend
Increase in use of LAI antipsychotic drugs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Schizophrenia: Disease overview
Schizophrenia
Medical intervention for treating schizophrenia
Non-medical interventions for treating schizophrenia
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-schizophrenia-therapeutics-market-2017-2021-report.html/toc
PART 06: Key clinical trials
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation based on drug-class
First-generation antipsychotic drugs
Second-generation antipsychotic drugs
Third generation antipsychotic drugs
PART 09: Geographical segmentation
Market overview based on geography
Schizophrenia therapeutics market in Americas
Schizophrenia therapeutics market in EMEA
Schizophrenia therapeutics market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
Market drivers
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
About Schizophrenia Therapeutics
Schizophrenia is a chronic mental disorder that alters the perception, thinking, and social behavior of an individual. Individuals suffering from this disease face difficulty in distinguishing between imaginary things and reality. Although schizophrenia is not as prevalent as other mental disorders, it affects 7 or 8 individuals out of 1,000 people. Globally, the disease affects 1% of the total population. Schizophrenic patients are usually diagnosed with low levels of dopamine and serotonin. These are major neurotransmitters in the brain and are responsible for transmitting nerve signals from one neuron to another neuron. Deficiency of these neurons in the brain leads to impairment of thinking, perception, and the activity of an individual. At present, the treatment regimen for this disease focuses on relieving symptoms. Thus, antipsychotic drugs are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.
Technavios analysts forecast the global schizophrenia therapeutics market to grow at a CAGR of 1.84% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global schizophrenia therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1267319
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Schizophrenia Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Other prominent vendors
Alkermes
Bristol-Myers Squibb
Market driver
Increasing expenditure on prescription drugs
For a full, detailed list, view our report
Market challenge
Technological advances in non-invasive neuromodulation devices
For a full, detailed list, view our report
Market trend
Increase in use of LAI antipsychotic drugs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Schizophrenia: Disease overview
Schizophrenia
Medical intervention for treating schizophrenia
Non-medical interventions for treating schizophrenia
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-schizophrenia-therapeutics-market-2017-2021-report.html/toc
PART 06: Key clinical trials
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation based on drug-class
First-generation antipsychotic drugs
Second-generation antipsychotic drugs
Third generation antipsychotic drugs
PART 09: Geographical segmentation
Market overview based on geography
Schizophrenia therapeutics market in Americas
Schizophrenia therapeutics market in EMEA
Schizophrenia therapeutics market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
Market drivers
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
